AC Immune S.A. (ACIU)
AC Immune S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
AC Immune S.A. (ACIU) is a Biotechnology company based in CH with a market capitalization of $234.1M. Revenue declined 86.9% year-over-year and free cash flow was negative at -$67M. This page tracks ACIU's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CH · 133 employees · IPO Sep 23, 2016
Valuation
Valuation & price
$2.95as of May 26, 2026· -26.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$234.1M
Market cap
-86.9%
Revenue growth (YoY)
100.0%
Gross margin
-$67M
Free cash flow (USD)
-$87M
Net debt
Net cash position
1.1%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 6-K filed Jun 30, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Annual reportJun 30, 2026Filing
Annual Report Filed
- 6-K filingJun 11, 2026Filing
Research Grant Announcement
- Annual reportJun 11, 2026Filing
Annual Report Filed
- Insider sellMay 18, 2026Filing
Insider Sell $28KPfeifer Andrea · Director, Chief Executive Officer · $27.9K
- Annual reportMay 15, 2026Filing
Annual Report Filed
- Annual reportMay 12, 2026Filing
Annual Report Filed
- 6-K filingApr 30, 2026Filing
Phase 1b/2 Trial Update
- Annual reportApr 30, 2026Filing
Annual Report Filed
- Insider buyApr 16, 2026Filing
Insider Buy $31KPfeifer Andrea · Director, Chief Executive Officer · $31.4K
- Insider sellApr 16, 2026Filing
Insider Sell $31KPfeifer Andrea · Director, Chief Executive Officer · $31.4K
Questions
Frequently asked questions
What is AC Immune S.A.'s market cap?
AC Immune S.A. (ACIU) has a market capitalization of $234.1M.
What is ACIU's P/E ratio?
A meaningful P/E ratio is not available for ACIU — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
Are insiders buying ACIU stock?
SEC Form 4 filings show no open-market insider buys at AC Immune S.A. in the last 90 days (1 sell).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.